« Photocopy machines and occupational antiphospholipid syndrome
The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione »

Influenza Drug Labels Get Warnings for Neuropsychiatric Changes

FDA says some chemicals cause neuropsychiatric changes

Recalls and Warnings Influenza Drug Labels Get Warnings for Neuropsychiatric Changes Patients with influenza should be closely monitored for signs of abnormal behavior during treatment with Tamiflu and possibly also Relenza. (US Food and Drug Administration.)

Medscape Medical News
http://www.medscape.com/viewarticle/570996?sssdmh=dm1.339468&src=nldne

Tags:

This entry was posted on Monday, January 26th, 2009 at 4:36 pm and is filed under Influenza, Relenza, Tamiflu. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.